Pregmerve
Sources
Pregmerve (Multivitamin/Folate)
Clinical Summary
Pregmerve is an Indian brand multivitamin supplement containing folic acid and other vitamins/minerals, typically marketed as a prenatal/postnatal supplement but commonly prescribed as a general multivitamin/folate supplement for non-pregnant women.
Documented on November 2022 medication list as "1 tab once daily, morning."
Status: Discontinued. Not present on the May 2026 handwritten prescription. Likely replaced by Renerve (methylcobalamin B12 + B6 + alpha-lipoic acid + folate), which was documented as active in April 2026.
Dosing History
| Date | Dose | Frequency | Route | Context | Status |
|---|---|---|---|---|---|
| 2022-11-25 | 1 tab | Once daily (morning) | Oral | Nov 2022 medication list | Active |
| Unknown (between 2022–2026) | — | — | — | Not on 2026 Rx | Discontinued |
[!info] Likely Replaced by Renerve
Both Pregmerve (2022) and Renerve (2026) contain folate and B-vitamins. The transition from Pregmerve to Renerve represents an upgrade to a more targeted neurological B-vitamin complex (methylcobalamin + B6 + alpha-lipoic acid + folate), possibly driven by neuropathy concerns or the addition of pregabalin to the regimen.
Related
- Renerve — Current B-vitamin supplement (likely successor)
- Pregabalin — Also new post-2022 (neuropathy co-management)
Medication page created 2026-05-06 from Nov 2022 historical medication list (raw/clinic-notes/2026-05-06_note.md). Discontinued at unknown date before 2026-05-04.